Can I give Halls (menthol lozenges) suckers to a 2-year-old child with symptoms of a respiratory infection, such as cough or sore throat?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 26, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Do Not Give Halls Menthol Lozenges to a 2-Year-Old Child

Halls menthol lozenges and all over-the-counter cough and cold medications are contraindicated in children under 2 years of age due to lack of efficacy and serious safety risks including death. 1, 2

Why Halls Are Dangerous for Toddlers

Choking Hazard

  • Menthol lozenges pose a significant choking risk in children under 4 years who lack the developmental ability to safely manage hard candy in their mouth 3
  • The physical form of a lozenge requires coordination that 2-year-olds have not yet developed 3

FDA and AAP Position on Cough/Cold Products

  • The FDA and American Academy of Pediatrics explicitly recommend against prescribing or using over-the-counter cough and cold medications, including menthol products, for children under 2 years 1, 2
  • Between 1969-2006, there were 69 fatalities associated with cough and cold medications in children under 6 years, with 41 deaths occurring in children under 2 years 4, 5
  • An estimated 1,519 children under 2 years were treated in U.S. emergency departments during 2004-2005 for adverse events related to cough and cold medications 2

Lack of Efficacy Evidence

  • No FDA-approved dosing recommendations exist for cough and cold medications in children under 2 years 2
  • Published evidence supporting effectiveness of menthol or other OTC antitussives in this age group is absent 6
  • The dosages at which these medications can cause illness or death in young children are not known 2

Safe Alternatives for Respiratory Symptoms

First-Line Supportive Care

  • Maintain adequate hydration through continued breastfeeding or formula feeding to help thin secretions 1
  • Gentle nasal suctioning with a bulb syringe helps clear secretions and improve breathing 1
  • Supported sitting position during feeding and rest helps expand lungs and improve respiratory symptoms 1
  • Weight-based acetaminophen for fever and discomfort (if child is uncomfortable), which can help reduce coughing episodes 1

Evidence-Based Symptomatic Relief

  • Buckwheat honey (1.5 mL before bedtime) improves cough symptoms in children over 12 months, but is contraindicated under 12 months due to botulism risk 7, 6
  • Vapor rub applied topically to chest and neck (not menthol lozenges) may provide symptomatic relief in children over 2 years 7, 6
  • Nasal saline irrigation provides modest benefit for reducing nasal congestion symptoms with minimal side effects 4

Expected Clinical Course and Red Flags

Normal Recovery Timeline

  • Most viral upper respiratory infections resolve within 1-3 weeks, with 90% of children cough-free by day 21 1
  • Mean cough resolution occurs at 8-15 days after infection onset 1

When to Seek Immediate Medical Attention

  • Respiratory rate >70 breaths/minute (infants) or >50 breaths/minute (toddlers) 1
  • Difficulty breathing, grunting, or cyanosis (blue discoloration) 1
  • Oxygen saturation <92% 1
  • Poor feeding or signs of dehydration (decreased wet diapers, sunken fontanelle, no tears when crying) 1
  • Persistent high fever ≥100.4°F (38°C) rectally or ≥39°C for 3+ consecutive days 1

Critical Pitfall to Avoid

Never use any form of menthol product, topical decongestant, antihistamine, or cough suppressant in children under 2 years without explicit physician guidance. The narrow therapeutic window and risk of cardiovascular and CNS toxicity make these products dangerous in this age group. 1, 5

References

Guideline

Management of Viral Upper Respiratory Tract Infections in Children

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Infant deaths associated with cough and cold medications--two states, 2005.

MMWR. Morbidity and mortality weekly report, 2007

Research

The Use and Safety of Cough and Cold Medications in the Pediatric Population.

The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG, 2025

Guideline

Alternatives to Cetirizine for Allergic Rhinitis in Children Under 2 Years

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Management of Nasal Congestion in Viral Upper Respiratory Infections

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Treatment of the common cold in children and adults.

American family physician, 2012

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.